The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.50
Bid: 68.00
Ask: 69.00
Change: 2.50 (3.76%)
Spread: 1.00 (1.471%)
Open: 68.00
High: 69.00
Low: 65.50
Prev. Close: 66.50
TRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement regarding Satago and Trading Update

20 Jan 2023 07:00

RNS Number : 3311N
TruFin PLC
20 January 2023
 

20 January 2023

 

TruFin plc("TruFin" or the "Company")

 

Statement regarding Satago and Trading Update

 

Statement regarding Satago

 

TruFin is pleased to announce that Satago Financial Solutions Limited ("Satago") has delivered the trial phase of its fully digitised end-to-end invoice finance solution with Lloyds Bank plc (the "Bank"). The Bank is now testing the digitised proposition ahead of customer onboarding. We look forward to updating shareholders on the progress of this partnership in due course.

 

Trading update

 

Revenues for the 12 months ended 31 December 2022 are expected to be no less than £16.0m (FY21: £13.1m), representing year-on-year growth in excess of 22%. This has predominantly been driven by revenue growth of more than 350% at Satago and over 25% growth at Oxygen Finance Group Limited (together with its subsidiaries Oxygen Finance Limited and Oxygen Finance Americas) ("Oxygen").

 

The Adjusted Loss Before Tax is expected to be in line with market expectations at no more than £8.1m (FY21: £8.4m).

 

Oxygen

 

Oxygen continued to make considerable progress during 2022. Revenue is expected to be no less than £5.3m (FY21: £4.1m) and EBITDA is expected to more than double to not less than £1.1m (FY21: £0.5m). Given its robust progress and strong financial outlook, Oxygen made its first dividend payment (of £0.25m) to TruFin in December.

 

Oxygen dominates its niche markets and is becoming increasingly attractive to a growing pool of potential acquirers - as demonstrated by the recent unsolicited indicative offer which the Board of TruFin rejected, as announced on 22 December 2022.

 

Satago

 

Revenues increased more than 350% to no less than £2.1m (FY21: £0.5m). Growth was driven by Satago's successful pivot towards lending as a service ("LaaS") which, combined with its targeted proprietary lending book, make it increasingly attractive to other commercial partners. 

 

Satago's focus is to deliver on significant contracts signed in 2022 and to win new customers from an exciting pipeline of opportunities.

 

Playstack

 

During 2022 Playstack Limited ("Playstack") launched two critically acclaimed games, The Entropy Centre and The Case of the Golden Idol. It also successfully integrated Magic Fuel Inc. ("Magic Fuel") following acquisition of the remote games developer in June and delivered on key contract milestones for their technology platform partner.

 

Revenues in FY22 are expected to be no less than £6.2m (FY21: £7.1m), following the previously announced delay to a key console game title. The rescheduled game launch is not expected to impact the financial support that Playstack requires from TruFin.

 

2023 is expected to be key for Playstack. Several landmark game launches are planned throughout the year and it boasts a growing collection of exciting titles to evaluate, selected by Magnitude, Playstack's proprietary sourcing technology.

 

Vertus

 

Vertus Capital Limited ("Vertus") continues to perform well, with no credit losses incurred to date and an increasing pipeline of opportunities. Vertus recorded its second full year of profitability during FY22, with profit before tax at no less than £0.2m (FY21: £0.01m). Despite two early repayments, its loan book grew by over 38% to £21.4m (FY21: £15.6m). New loan facilities grew very strongly, up 80%. Revenue increased 57% to £2.2m (FY21: £1.4m) and Vertus' unique position in the marketplace ensures it is well-positioned to achieve another full year of profitable growth during 2023.

 

James van den Bergh, Chief Executive Officer, commented:

 

"Despite a tough macroeconomic backdrop, 2022 was another year of significant progress for TruFin. Numerous internal records at Oxygen culminated in their inaugural dividend to TruFin - highlighting their position as a financially independent subsidiary. Satago's two partnerships with FTSE100 companies were particularly pleasing to conclude and with revenue growth of more than 350% the direction of travel is clear. Playstack's acquisition of Magic Fuel and its growing portfolio of opportunities should allow 2023 to be a transition year for Playstack, whilst Vertus achieved their second full year of profitable growth.

 

The Board is confident that there is scope for significant value creation for our shareholders and we look forward to updating them on progress in the coming months."

 

The information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. By the publication of this Announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this Announcement on behalf of the Company is Annie Styler.

For further information, please contact:

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

0203 743 134007779 229508

Liberum Capital Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward Thomas

0203 100 2000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBKLLFXFLBBBK
Date   Source Headline
12th Apr 20247:01 amRNSBlock Admission Application
12th Apr 20247:00 amRNSGrant of share awards under LTIP
2nd Apr 20247:00 amRNSAppointment of Director to the Board of Playstack
26th Mar 20247:01 amRNSSale of Interact platform
25th Mar 20247:00 amRNSSatago signs contract with Bank of Ireland Finance
19th Mar 20247:00 amRNSNotice of Results and Investor Presentation
18th Mar 20247:00 amRNSPlaystack announces over 1m units sold for Balatro
12th Mar 202411:07 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSPlaystack releases its fastest selling game
8th Feb 20247:00 amRNSTrading Update
4th Jan 20247:00 amRNSTrading Update
20th Dec 20239:40 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSAppointment of INED to the Board of Oxygen
21st Nov 20237:00 amRNSPlaystack enters into LoI for sale of Interact
9th Nov 20237:00 amRNSOxygen Finance acquisition of bidstats.uk
18th Oct 20234:19 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSSale of Majority Holding in Vertus
29th Sep 20237:00 amRNSHalf-year Report
28th Sep 202312:07 pmRNSResult of AGM
14th Sep 20238:00 amRNSPlaystack releases award-winning game - AK-xolotl
29th Aug 20236:19 pmRNSNotice of AGM
21st Aug 20237:00 amRNSNon-Binding Offer for Vertus
28th Jul 20237:00 amRNSGrant of Share Awards under LTIP
18th Jul 20238:59 amRNSHolding(s) in Company
18th Jul 20238:58 amRNSHolding(s) in Company
18th Jul 20238:55 amRNSHolding(s) in Company
10th Jul 202312:03 pmRNSResult of GM and Result of Placing and Open Offer
23rd Jun 20237:00 amRNSResult of Placing and Notice of General Meeting
22nd Jun 20234:45 pmRNSProposed Placing and Open Offer
18th May 20233:04 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSOxygen Finance secures six Early Payment contracts
15th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
28th Feb 20235:43 pmRNSHolding(s) in Company
23rd Jan 20237:00 amRNSStatement re Satago
20th Jan 20237:00 amRNSStatement regarding Satago and Trading Update
22nd Dec 20227:00 amRNSRejected Indicative Offer for Oxygen
15th Nov 20227:00 amRNSOxygen surpasses £1b in early payment provision
3rd Nov 20227:00 amRNSPlaystack releases new console game
20th Oct 20227:00 amRNSSatago signs agreement with Sage
10th Oct 20227:00 amRNSNotice of Capital Markets Day
30th Sep 20227:00 amRNSPDMR Notification
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Capital Markets Day
25th Aug 20229:37 amRNSHolding(s) in Company
29th Jul 20229:00 amRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSSatago signs commercial agreement with Lloyds
1st Jul 20227:00 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSSatago partnership with Sage and Lloyds
7th Jun 202211:19 amRNSResult of AGM
6th Jun 20227:00 amRNSStatement re Playstack

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.